Yervoy Market Report 2026
Yervoy Market Global Report 2026 Market Report Infographic Image

Published : April 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Yervoy Market Report 2026

Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Yervoy Market Overview

• The Yervoy market growth in the historic period has been driven by approval for melanoma and solid tumors, success of ctla-4 inhibition

• Market expansion is supported by expansion of immunotherapy pipelines, growth of combination regimens

• Growth Driver: Increasing Incidence of Melanoma Drives Demand for Advanced Treatment Solutions

• Market Trend: Innovative Combination Therapies Yervoy And Opdivo Lead The Way In Cancer Treatment Advancements

North America was the largest region in 2025.

What Is Covered Under Yervoy Market?

Yervoy is a prescription medication containing ipilimumab, a monoclonal antibody used in the treatment of certain cancers by enhancing the body's immune system to fight cancer cells. It is a monoclonal antibody that works by blocking the CTLA-4 (cytotoxic T-lymphocyte antigen 4) receptor on T-cells, a protein that normally downregulates the immune response.

The main types of yervoy are 40 ml, and 10 ml. The Yervoy 40 mg dose refers to a specific concentration of ipilimumab, a monoclonal antibody used in immunotherapy, administered to patients to activate the immune system by inhibiting CTLA-4, a protein receptor that downregulates immune responses, thereby enhancing the body's ability to target and destroy cancer cells in conditions such as metastatic melanoma and other cancers as per the prescribed treatment regimen. The various indication includes melanoma, non-small cell lung cancer (nsclc), renal cell carcinoma (rcc), and colorectal cancer (crc). These are distributed through various distribution channels such as hospitals, oncology clinics, retail pharmacies, online pharmacies and used by various end users such as adults, geriatric.

Yervoy Market Global Report 2026 Market Report bar graph

What Is The Yervoy Market Size and Share 2026?

The yervoy market size has grown rapidly in recent years. It will grow from $6.01 million in 2025 to $6.66 million in 2026 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to approval for melanoma and solid tumors, success of ctla-4 inhibition, oncology center adoption, unmet needs in advanced cancers, improved survival outcomes.

What Is The Yervoy Market Growth Forecast?

The yervoy market size is expected to see rapid growth in the next few years. It will grow to $9.93 million in 2030 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to expansion of immunotherapy pipelines, growth of combination regimens, increasing cancer prevalence, rising oncology investments, improved immune profiling. Major trends in the forecast period include growth of immune checkpoint inhibitors, expansion of combination immunotherapy, rising use in advanced oncology, hospital based immuno oncology care, focus on long term cancer survival.

Customer representative image Book your 30 minutes free consultation with our research experts

Global Yervoy Market Segmentation

1) By Type: 40 ml, 10 ml

2) By Clinical Indication: Melanoma, Non-Small Cell Lung Cancer (NSCLC), Renal Cell Carcinoma (RCC), Colorectal Cancer (CRC)

3) By Distribution Channel: Hospitals, Oncology Clinics, Retail Pharmacies, Online Pharmacies

4) By End User: Adult, Geriatric

What Is The Driver Of The Yervoy Market?

The increasing incidence of melanoma is expected to propel the growth of the yervoy market going forward. Melanoma refers to a type of skin cancer that develops in the melanocytes, which produce the pigment melanin responsible for skin color. The rising incidence of melanoma is driven by increased sun exposure, lifestyle changes, and UV radiation due to ozone depletion. Improved awareness and diagnostic methods also contribute to more cases being detected. Yervoy, by targeting the CTLA-4 protein to boost the immune system's ability to detect and attack cancer cells, has proven particularly beneficial for melanoma patients, offering improved survival rates and durable responses even in advanced stages of the disease. For instance, in January 2024, according to the American Cancer Society, a US- based non-profit organization dedicated to eliminating cancer, reported that approximately 100,640 new melanoma cases are expected to be diagnosed in the United States in 2024, with 59,170 cases in men and 41,470 cases in women. Additionally, the organization estimates that 8,290 people will die from melanoma in 2024, with 5,430 men and 2,860 women affected. Therefore, increasing incidence of melanoma drives the yervoy industry.

Key Players In The Global Yervoy Market

Major companies operating in the yervoy market are Bristol-Myers Squibb, Merck & Co., Ono Pharmaceutical

Global Yervoy Market Trends and Insights

Major companies operating in the yervoy market are focusing on developing innovative combination therapies, such as a combination of Opdivo (nivolumab) and yervoy (ipilimumab), to enhance treatment efficacy and broaden the range of cancer indications. The combination of Opdivo (nivolumab) and Yervoy (ipilimumab) synergistically boosts the immune response by targeting complementary immune checkpoint pathways, enhancing efficacy in treating various cancers such as melanoma and renal cell carcinoma. For instance, in June 2024, Bristol Myers Squibb, a US-based company that manufactures pharmaceuticals, announced significant results from the CheckMate-9DW trial, which evaluated the combination of Opdivo (nivolumab) and Yervoy (ipilimumab) as a first-line treatment for patients with advanced hepatocellular carcinoma (HCC). The trial demonstrated that this dual immunotherapy regimen significantly improved overall survival (OS) compared to the standard treatments, lenvatinib or sorafenib. The combination of Opdivo and Yervoy showed a statistically significant improvement in overall survival for patients with advanced HCC compared to those treated with either lenvatinib or sorafenib.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Yervoy Market?

In September 2024, Ono Pharmaceutical, a Japan-based company that manufactures pharmaceuticals, partnered with Bristol-Myers Squibb KK (BMS KK). This partnership aims to expand the use of Opdivo and Yervoy in treating unresectable advanced or recurrent microsatellite instability-high (MSI-H) colorectal cancer. Through this collaboration, Ono aims to enhance its portfolio of immuno-oncology therapies and address unmet medical needs in cancer treatment. Bristol-Myers Squibb is a Japan-based company that offers yervoy.

Regional Insights

North America was the largest region in the yervoy market in 2025. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Yervoy Market?

The yervoy market consists of sales of ipilimumab and combination therapies. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Yervoy Market Report 2026?

The yervoy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the yervoy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Yervoy Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $ billion
Revenue Forecast In 2035 $ billion
Growth Rate CAGR of 10.8% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Clinical Indication, Distribution Channel, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Bristol-Myers Squibb, Merck & Co., Ono Pharmaceutical
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Yervoy Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Yervoy Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Yervoy Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Yervoy Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Growth Of Immune Checkpoint Inhibitors

4.2.2 Expansion Of Combination Immunotherapy

4.2.3 Rising Use In Advanced Oncology

4.2.4 Hospital Based Immuno Oncology Care

4.2.5 Focus On Long Term Cancer Survival

5. Yervoy Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Oncology Clinics

5.3 Cancer Treatment Centers

5.4 Academic Medical Centers

5.5 Specialty Oncology Institutes

6. Yervoy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Yervoy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Yervoy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Yervoy Market Size, Comparisons And Growth Rate Analysis

7.3. Global Yervoy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Yervoy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Yervoy Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Yervoy Market Segmentation

9.1. Global Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

40 ml, 10 ml

9.2. Global Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Melanoma, Non-Small Cell Lung Cancer (NSCLC), Renal Cell Carcinoma (RCC), Colorectal Cancer (CRC)

9.3. Global Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Oncology Clinics, Retail Pharmacies, Online Pharmacies

9.4. Global Yervoy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adult, Geriatric

10. Yervoy Market Regional And Country Analysis

10.1. Global Yervoy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Yervoy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Yervoy Market

11.1. Asia-Pacific Yervoy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Yervoy Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Yervoy Market

12.1. China Yervoy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Yervoy Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Yervoy Market

13.1. India Yervoy Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Yervoy Market

14.1. Japan Yervoy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Yervoy Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Yervoy Market

15.1. Australia Yervoy Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Yervoy Market

16.1. South Korea Yervoy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

16.2. South Korea Yervoy Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Yervoy Market

17.1. Western Europe Yervoy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. Western Europe Yervoy Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Yervoy Market

18.1. UK Yervoy Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Yervoy Market

19.1. Germany Yervoy Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Yervoy Market

20.1. France Yervoy Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Yervoy Market

21.1. Eastern Europe Yervoy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

21.2. Eastern Europe Yervoy Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Yervoy Market

22.1. North America Yervoy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

22.2. North America Yervoy Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Yervoy Market

23.1. USA Yervoy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

23.2. USA Yervoy Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Yervoy Market

24.1. Canada Yervoy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

24.2. Canada Yervoy Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Yervoy Market

25.1. South America Yervoy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

25.2. South America Yervoy Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Yervoy Market

26.1. Middle East Yervoy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Middle East Yervoy Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Yervoy Market

27.1. Africa Yervoy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

27.2. Africa Yervoy Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Yervoy Market Regulatory and Investment Landscape

29. Yervoy Market Competitive Landscape And Company Profiles

29.1. Yervoy Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Yervoy Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Yervoy Market Company Profiles

29.3.1. Bristol-Myers Squibb Overview, Products and Services, Strategy and Financial Analysis

29.3.2. Merck & Co. Overview, Products and Services, Strategy and Financial Analysis

29.3.3. Ono Pharmaceutical Overview, Products and Services, Strategy and Financial Analysis

30. Global Yervoy Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Yervoy Market

32. Yervoy Market High Potential Countries, Segments and Strategies

32.1 Yervoy Market In 2030 - Countries Offering Most New Opportunities

32.2 Yervoy Market In 2030 - Segments Offering Most New Opportunities

32.3 Yervoy Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Yervoy Market, Overview Of Key Products - Product Examples
  • Table 2: Global Yervoy Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Yervoy Market, Supply Chain Analysis
  • Table 4: Global Yervoy Market, Major Raw Material Providers
  • Table 5: Global Yervoy Market, Major Resource Providers
  • Table 6: Global Yervoy Market, Major Manufacturers (Suppliers)
  • Table 7: Global Yervoy Market, Major Distributors And Channel Partners
  • Table 8: Global Yervoy Market, Key Technologies & Future Trends
  • Table 9: Global Yervoy Market, Major Trends
  • Table 10: Global Yervoy Market, Major End Users
  • Table 11: Global Yervoy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Yervoy Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Yervoy Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Yervoy Market - TAM, US$ Billion, 2025
  • Table 15: Global Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Yervoy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Yervoy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Yervoy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Asia-Pacific, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: China, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: India, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: Japan, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Australia, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: South Korea, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: South Korea, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: South Korea, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Western Europe, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Western Europe, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Western Europe, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: UK, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: UK, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: UK, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Germany, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Germany, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Germany, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: France, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: France, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: France, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Eastern Europe, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Eastern Europe, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Eastern Europe, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: North America, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: North America, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: North America, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: USA, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: USA, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: USA, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Canada, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Canada, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Canada, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: South America, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: South America, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: South America, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Middle East, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Middle East, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Middle East, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Africa, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Africa, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Africa, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Global Yervoy Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 73: Global Yervoy Market - Company Scoring Matrix
  • Table 74: Bristol-Myers Squibb Financial Performance
  • Table 75: Merck & Co. Financial Performance
  • Table 76: Ono Pharmaceutical Financial Performance
  • Table 77: Global Yervoy Market, Competitive Benchmarking (In USD Billions)
  • Table 78: Global Yervoy Market, Competitive Dashboard
  • Table 79: Global Yervoy Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 80: Global, Yervoy Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 81: Global, Yervoy Market Size Gain ($ Billion), Segmentation By Clinical Indication, 2025 – 2030
  • Table 82: Global, Yervoy Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

    Figure 1: Global Yervoy Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Yervoy Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Yervoy Market, Supply Chain Analysis
  • Figure 4: Global Yervoy Market, Major Raw Material Providers
  • Figure 5: Global Yervoy Market, Major Resource Providers
  • Figure 6: Global Yervoy Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Yervoy Market, Major Distributors And Channel Partners
  • Figure 8: Global Yervoy Market, Key Technologies & Future Trends
  • Figure 9: Global Yervoy Market, Major Trends
  • Figure 10: Global Yervoy Market, Major End Users
  • Figure 11: Global Yervoy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Yervoy Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Yervoy Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Yervoy Market - TAM, US$ Billion, 2025
  • Figure 15: Global Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Yervoy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Yervoy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Yervoy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Asia-Pacific, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: China, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: India, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: Japan, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Australia, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: South Korea, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: South Korea, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: South Korea, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Western Europe, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Western Europe, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Western Europe, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: UK, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: UK, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: UK, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Germany, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Germany, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Germany, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: France, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: France, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: France, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Eastern Europe, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Eastern Europe, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Eastern Europe, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: North America, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: North America, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: North America, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: USA, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: USA, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: USA, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Canada, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Canada, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Canada, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: South America, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: South America, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: South America, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Middle East, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Middle East, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Middle East, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Africa, Yervoy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Africa, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Africa, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Global Yervoy Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 73: Global Yervoy Market - Company Scoring Matrix
  • Figure 74: Bristol-Myers Squibb Financial Performance
  • Figure 75: Merck & Co. Financial Performance
  • Figure 76: Ono Pharmaceutical Financial Performance
  • Figure 77: Global Yervoy Market, Competitive Benchmarking (In USD Billions)
  • Figure 78: Global Yervoy Market, Competitive Dashboard
  • Figure 79: Global Yervoy Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 80: Global, Yervoy Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 81: Global, Yervoy Market Size Gain ($ Billion), Segmentation By Clinical Indication, 2025 – 2030
  • Figure 82: Global, Yervoy Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Frequently Asked Questions

The Yervoy market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

The global Yervoy market is expected to grow at a CAGR of 10.5% from 2026 to 2035 to reach $ billion by 2035.

Some Key Players in the Yervoy market Include, Bristol-Myers Squibb, Merck & Co., Ono Pharmaceutical .

Major trend in this market includes: Innovative Combination Therapies Yervoy And Opdivo Lead The Way In Cancer Treatment Advancements. For further insights on this market. request a sample here

North America was the largest region in the yervoy market in 2025. The regions covered in the yervoy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts